Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Brealey

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Critical Care (London, England)|March 3, 2025
An international observational study validating gene-expression sepsis immune subgroupsDavid B Antcliffe, Estelle Peronnet, Frédéric Pène, et al.
Intensive Care Medicine|February 17, 2025
INHALE WP3, a multicentre, open-label, pragmatic randomised controlled trial assessing the impact of rapid, ICU-based, syndromic PCR, versus standard-of-care on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumoniaVirve I Enne, Susan Stirling, Julie A Barber, et al.
The Lancet. Respiratory Medicine|March 26, 2026
Bedside identification of subphenotypes in acute respiratory failure (PHIND): a multicentre, observational cohort studyKiran Reddy, Pratik Sinha, David B Antcliffe, et al.
JAMA|May 19, 2025
Dexmedetomidine- or Clonidine-Based Sedation Compared With Propofol in Critically Ill Patients: The A2B Randomized Clinical TrialTimothy S Walsh, Richard A Parker, Leanne M Aitken, et al.
American Journal of Respiratory and Critical Care Medicine|May 8, 2023
Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical TrialEllen A Gorman, Jennifer Rynne, Hannah J Gardiner, et al.
JAMA|December 9, 2024
Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical TrialPaul Dark, Anower Hossain, Daniel F McAuley, et al.
Intensive Care Medicine|April 11, 2018
Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)Tobias Welte, R Phillip Dellinger, Henning Ebelt, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Critical Care (London, England)|March 3, 2025
An international observational study validating gene-expression sepsis immune subgroupsDavid B Antcliffe, Estelle Peronnet, Frédéric Pène, et al.
Intensive Care Medicine|February 17, 2025
INHALE WP3, a multicentre, open-label, pragmatic randomised controlled trial assessing the impact of rapid, ICU-based, syndromic PCR, versus standard-of-care on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumoniaVirve I Enne, Susan Stirling, Julie A Barber, et al.
The Lancet. Respiratory Medicine|March 26, 2026
Bedside identification of subphenotypes in acute respiratory failure (PHIND): a multicentre, observational cohort studyKiran Reddy, Pratik Sinha, David B Antcliffe, et al.
JAMA|May 19, 2025
Dexmedetomidine- or Clonidine-Based Sedation Compared With Propofol in Critically Ill Patients: The A2B Randomized Clinical TrialTimothy S Walsh, Richard A Parker, Leanne M Aitken, et al.
American Journal of Respiratory and Critical Care Medicine|May 8, 2023
Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical TrialEllen A Gorman, Jennifer Rynne, Hannah J Gardiner, et al.
JAMA|December 9, 2024
Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical TrialPaul Dark, Anower Hossain, Daniel F McAuley, et al.
Intensive Care Medicine|April 11, 2018
Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)Tobias Welte, R Phillip Dellinger, Henning Ebelt, et al.
Pageof 9